Trial Outcomes & Findings for 2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses (NCT NCT05126953)
NCT ID: NCT05126953
Last Updated: 2025-07-20
Results Overview
Normalized logMAR visual acuity is the change in visual acuity (how well you can see) from baseline (spectacle). Normalized visual acuity is calculated by subtracting the logMAR visual acuity with a contact lens from the baseline (refraction without a contact lens). Each letter on the logMAR visual acuity chart has a value of 0.02.
COMPLETED
NA
30 participants
Assessed at 2-hour post-baseline
2025-07-20
Participant Flow
This is a contralateral study. 30 subjects were enrolled and were dispensed lenses based on a randomization schedule.
Unit of analysis: Eyes
Participant milestones
| Measure |
Samfilcon A Lenses With EPG01 Packaging Solution and Commercially Available B+L Ultra Lenses.
Each participant wore the test lens in one eye and the control lens in the fellow eye for 2 hours.
|
|---|---|
|
Overall Study
STARTED
|
30 60
|
|
Overall Study
Samfilcon A Lenses With EPG01 Packaging Solution
|
30 30
|
|
Overall Study
B+L Ultra Lenses
|
30 30
|
|
Overall Study
COMPLETED
|
30 60
|
|
Overall Study
NOT COMPLETED
|
0 0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses
Baseline characteristics by cohort
| Measure |
Samfilcon A Lenses With EPG01 Packaging Solution and Commercially Available B+L Ultra Lenses.
n=60 Eyes
Participants were implanted with both samfilcon A Lenses with EPG01 Packaging Solution and commercially available B+L Ultra lenses.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=30 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
30 Participants
n=30 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=30 Participants
|
|
Age, Continuous
|
40.7 Years
STANDARD_DEVIATION 12.62 • n=30 Participants
|
|
Sex: Female, Male
Female
|
12 Participants
n=30 Participants
|
|
Sex: Female, Male
Male
|
18 Participants
n=30 Participants
|
|
Region of Enrollment
United States
|
30 participants
n=30 Participants
|
PRIMARY outcome
Timeframe: Assessed at 2-hour post-baselineNormalized logMAR visual acuity is the change in visual acuity (how well you can see) from baseline (spectacle). Normalized visual acuity is calculated by subtracting the logMAR visual acuity with a contact lens from the baseline (refraction without a contact lens). Each letter on the logMAR visual acuity chart has a value of 0.02.
Outcome measures
| Measure |
Samfilcon A Lenses With EPG01 Packaging Solution
n=30 Lenses
Participants were implanted with samfilcon A Lenses with EPG01 Packaging Solution
|
Commercially Available B+L Ultra Lenses
n=30 Lenses
Participants were implanted with commercially available B+L Ultra lenses.
|
|---|---|---|
|
Normalized logMAR Visual Acuity
INS visit
|
0.005 LogMAR units
Standard Deviation 0.0577
|
0.003 LogMAR units
Standard Deviation 0.0633
|
|
Normalized logMAR Visual Acuity
FUP visit
|
-0.001 LogMAR units
Standard Deviation 0.0663
|
0.008 LogMAR units
Standard Deviation 0.0632
|
Adverse Events
Samfilcon A Lenses With EPG01 Packaging Solution and Commercially Available B+L Ultra Lenses.
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place